Human gene patents: under whose control?

Nicol, Dianne

doi:10.5694/j.1326-5377.2003.tb05494.x

Topics

Medical genetics

Ethics and law

Balancing commercial patent rights and public interest is a complex matter

Faculty of Law, University of Tasmania, Hobart, TAS.

Correspondence:

Competing interests:

I am a member of the Advisory Committee to the Australian Law Reform Commission’s inquiry Gene Patenting and Human Health. The views expressed in this editorial are mine and are not in any way connected with the Australian Law Reform Commission or the Advisory Committee.

1. Walpole IR, Dawkins HJS, Sinden PD, O’Leary PC. Human gene patents: the possible impacts on genetic services healthcare. Med J Aust 2003; 179: 203-205. <MJA full text>
2. Essentially yours: the protection of human genetic information in Australia. ALRC Report 96. Canberra: Australian Law Reform Commission and Australian Health Ethics Committee, 2003. Available at: www.alrc.gov.au/publications/finalreps.htm (accessed Jun 2003).
3. Australian Law Reform Commission. Gene patenting [ALRC inquiry website]. Available at: www.alrc.gov.au/inquiries/current/patenting/ (accessed Jun 2003).
4. Manual of patent examining procedure. 8th ed., Feb 2003 revision. Washington, DC: United States Patent and Trademark Office, 2003; §2107. Available at: www.uspto.gov/web/offices/pac/mpep/index.html (accessed May 2003).
5. L’Institut Curie. Oppositions Myriad Genetics. Available at: www.curie.net/home/presse/actu_list.cfm/lang/_fr/affaire/3.htm (accessed Jun 2003).
6. General Steel Industries Inc v Commissioner of Railways (NSW) (1964) 112 CLR 125.
7. Stack v Brisbane City Council (1995) 32 IPR 69.
8. TRIPS (Trade-related aspects of intellectual property rights) material on the WTO website. Available at: www.wto.org/english/tratop_e/trips_e/trips_e.htm (accessed Jul 2003).

Online responses are no longer available. Please refer to our instructions for authors page for more information.